Omeros (OMER) Stock
Omeros (OMER) closed at $16.68 on Nov 16, 2026; its Tenet Score is 31 of 100 against 340 Healthcare peers.
49 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $16.68
- Nov 16, 2026
- Market cap
- $1.2B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 6.59 – 21.24
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 31/100
- Weak · 340 Healthcare peers
Industry: Drugs
Omeros Corporation scores 31/100. Weak. Quality is the soft spot versus 340 Healthcare peers. Insufficient inputs: Tenet 31 is built from 2 of 4 pillars, from 20% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=340Factor grades
Value & Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ~ Drawdown Context
- ~ Reversal Evidence
- ✕ Not-a-Value-Trap Gate
- ~ Qualified Dip
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Novavax, Inc.NVAX | 37 | $1.3B |
| Taysha Gene Therapies IncTSHA | 58 | $1.3B |
| Ocular Therapeutix IncOCUL | 51 | $1.3B |
| Innoviva IncINVA | 73 | $1.3B |
| Absci CorpABSI | 39 | $1.3B |
| Mineralys Therapeutics IncMLYS | 55 | $1.3B |
| Mannkind CorpMNKD | 29 | $1.3B |
| Amphastar Pharmaceuticals IncAMPH | 67 | $1.2B |
| Opko Health IncOPK | 43 | $1.2B |
| Cronos Group IncCRON | 72 | $1.2B |
Common questions
What sector and industry is Omeros in?
Omeros is in the Healthcare sector and the Drugs industry.
What is Omeros' Tenet Score?
Omeros' Tenet Score is 31 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




